NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Instruments & Supplies · USD

Baxter International Inc. (BAX) Stock Analysis

Baxter International Inc. (BAX) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

BAX

$25.83

+$0.26 (+1.02%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BAX with… →

BAX Key Statistics

As of Sep 4, 2026
Trading
Open
$25.33
Previous Close
$25.57
Day's Range
25.26–26.12
52-Week Range
15.73–30.00
Volume
3.42M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.59
Valuation
Market Cap
$13.35B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.68
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
36.68
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.16
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.90
Financials (FY)
Revenue (FY)
$11.24B+5.72%
Net Income (FY)
−$957.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
−9.27%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
517.00M
1-Year Return
+9.75%
Dividend and dates
Dividend
$0.04+0.15%
Ex-Dividend Date
August 28, 2026
Earnings Date
October 29, 2026estimated
Avg Volume
6.56M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BAX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+35.35%
2025−33.28%
2024−22.40%
2023−21.91%
2022−39.58%
2021+8.48%
2020−2.95%
2019+28.40%
2018+2.89%
2017+47.30%
2016 (partial year)−7.10%

As of September 4, 2026.

BAX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$11.24B−$957.00M−8.5%
2024$10.64B−$649.00M−6.1%
2023$10.36B$2.66B25.6%
2022$10.06B−$2.43B−24.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$11.24B$3.38B$177.00M−$957.00M−8.5%
2024$10.64B$3.98B$439.00M−$649.00M−6.1%
2023$10.36B$4.15B$707.00M$2.66B25.6%
2022$10.06B$3.55B−$33.00M−$2.43B−24.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BAX Dividend History

$0.52−50.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.033—
2025$0.524−50.0%
2024$1.044−10.3%
2023$1.164+0.9%
YearDividends per sharePaymentsChange
2026 (partial year)$0.033—
2025$0.524−50.0%
2024$1.044−10.3%
2023$1.164+0.9%
2022$1.154+6.0%
2021$1.094+13.6%
2020$0.964+12.4%
2019$0.854+16.4%
2018$0.734+19.7%
2017$0.614+369.2%
2016$0.131—

Most recent payment: $0.01 per share, ex-dividend August 28, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BAX Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricBAXMedical Instruments & Supplies medianvs median
P/S ratio1.163.1763% below
Profit margin−9.27%0.85%10.1 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Baxter International Inc. (BAX) at $13.35B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 37,500.

Over the past 52 weeks the price has ranged from $15.73 to $30.00. BAX last closed at $25.83 on September 4, 2026. That is +$0.26 (+1.02%) against the previous close. The latest close sits 64.21% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $11.24B. That is +5.72% against the prior fiscal year, when revenue was $10.64B. The same year closed with a net loss of $957.00M. The reported profit margin is −9.27%. That is 10.1 percentage points below the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are −1.9.

Across the 4 fiscal years on file, revenue moves from $10.06B in 2022 to $11.24B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 12.68. The PEG ratio, which sets the P/E against expected earnings growth, reads 36.68. The price-to-sales ratio is 1.16. On price-to-sales that is 63.31% below the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 0.6. Annualized volatility over the trailing 10 years is 29.86%. Over the trailing twelve months the price has returned +9.75%. Across 10 years the annualized return works out at −4.20%.

Growth & Income

The trailing dividend yield is 0.15%. That is 0.8 percentage points below the Medical Instruments & Supplies median yield of 0.97%. At the indicated rate that is $0.04 a share a year. The ex-dividend date on file is August 28, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.03 a share. The year before, 2025, totalled $0.52 a share.

The strongest complete calendar year on file is 2017 at +47.30%; the weakest is 2022 at −39.58%. Of the 9 complete calendar years on file, 4 finished higher. 2026 is still running; the price is +35.35% year to date.

Peer Comparison

Baxter International Inc. (BAX) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Baxter International Inc. BAX $13.35B —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Baxter International Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Visit website →